Rocket


Overview
Financials
News + Filings
Key Docs
Insiders

 
 

Satsuma Pharmaceuticals, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-18Dec-31-17
Revenues6.44.2
            Revenue growth53.4% 
Cost of goods sold7.54.9
Gross profit-1.1-0.8
            Gross margin-16.8%-18.0%
General and administrative1.10.8
EBIT-7.5-4.9
            EBIT margin-116.8%-118.0%
Pre-tax income0.00.0
Income taxes0.00.0
Net income0.00.0
            Net margin0.0%0.0%
 
Diluted EPS$0.00$0.00
Shares outstanding (diluted)1,026.9558.6
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy